# 4C Biomed (4C Biomed Limited)

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

- Company number: 12584675
- Status: Active
- Type: Private limited company
- Incorporated: 4 May 2020
- Registered office: Bd Business Centre, 17 Station Road, London, N11 1QJ
- Location: London
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does 4C Biomed do?

Private limited company registered in London, classed under “Research and experimental development on biotechnology”.

### How much turnover does 4C Biomed make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/4c-biomed-12584675

### Is 4C Biomed profitable?

4C Biomed's profit isn't public: small companies may file without a profit and loss account.

### How many people work at 4C Biomed?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/4c-biomed-12584675

### Who runs and owns 4C Biomed?

Its directors are David Rodney, Anthony Lionel Angel, Alan John Barge, Eyal Greenberg. Its owners are shown to subscribers.

### Where is 4C Biomed based?

Its registered office is Bd Business Centre, 17 Station Road, London, N11 1QJ, in London.

### When was 4C Biomed founded?

4C Biomed Limited was incorporated on 4 May 2020.

### Is 4C Biomed still trading?

The register lists 4C Biomed Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-07-22: Appointment of Dr Alan John Barge as a director on 1 May 2026
- 2026-05-21: Director's details changed for Mr Anthony Angel on 20 May 2025
- 2026-01-03: Accounts for a small company made up to 31 December 2024
- 2025-04-10: Accounts for a small company made up to 31 December 2023
- 2024-12-30: Current accounting period shortened from 30 December 2023 to 29 December 2023
- 2024-03-26: Accounts for a small company made up to 31 December 2022
- 2023-12-26: Previous accounting period shortened from 31 December 2022 to 30 December 2022
- 2023-11-20: Termination of appointment of Dan Teleman as a director on 14 November 2023
- 2023-08-24: Statement of capital following an allotment of shares on 27 June 2023 · USD 60,355 (and 7 more like it since 21 December 2020)
- 2023-01-12: Resolutions (and 4 more like it since 14 October 2020)
- 2023-01-12: Memorandum and Articles of Association (and 2 more like it since 14 October 2020)
- 2023-01-03: Appointment of Mr Dan Teleman as a director on 2 January 2023
- 2023-01-02: Appointment of Dr Eyal Greenberg as a director on 16 December 2022
- 2022-12-23: Change of share class name or designation (and 2 more like it since 23 December 2022)
- 2022-12-16: Accounts for a small company made up to 31 December 2021
- 2022-01-24: Total exemption full accounts made up to 31 December 2020
- 2020-12-23: Current accounting period shortened from 31 May 2021 to 31 December 2020
- 2020-12-22: Cessation of Anthony Angel as a person with significant control on 8 October 2020
- 2020-10-06: Cessation of David Rodney as a person with significant control on 3 September 2020
- 2020-10-06: Notification of Hilda Aaronson as a person with significant control on 3 September 2020
- 2020-10-06: Notification of Michael Aaronson as a person with significant control on 3 September 2020
- 2020-05-04: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/4c-biomed-12584675